Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

BUY
$68.26 - $76.19 $204 - $228
3 Added 0.0%
73,676 $5.61 Million
Q1 2024

May 08, 2024

SELL
$67.36 - $77.59 $852,575 - $982,056
-12,657 Reduced 14.66%
73,673 $5.4 Million
Q4 2023

Jan 23, 2024

SELL
$64.27 - $69.9 $443,463 - $482,310
-6,900 Reduced 7.4%
86,330 $6.01 Million
Q3 2023

Oct 13, 2023

SELL
$61.9 - $72.77 $80,470 - $94,601
-1,300 Reduced 1.38%
93,230 $6.23 Million
Q2 2023

Aug 08, 2023

BUY
$53.34 - $63.11 $5.04 Million - $5.97 Million
94,530 New
94,530 $5.97 Million
Q1 2021

May 13, 2021

SELL
$57.98 - $73.08 $3.05 Million - $3.84 Million
-52,599 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$62.61 - $71.29 $1.29 Million - $1.47 Million
-20,657 Reduced 28.2%
52,599 $3.75 Million
Q3 2020

Nov 12, 2020

BUY
$51.39 - $72.41 $3.76 Million - $5.3 Million
73,256 New
73,256 $5.1 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.55B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Ativo Capital Management LLC Portfolio

Follow Ativo Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ativo Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ativo Capital Management LLC with notifications on news.